3-AP and Cytarabine in Treating Patients With Hematologic Cancer

Clinical trial NCT00064090 · COMPLETED

Trial details

NCT number: NCT00064090
Sponsor: Vion Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Leukemia Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms

Start date: 2003-03-01
Primary completion: 2004-09-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.